Chairman of the Board
Anders Waas born 1957 is the Chairman of Sobrera Pharma since 2019. Waas has more than 35 years of experience with senior positions the pharmaceutical, biotechnology and med-tech industry. He has held senior global positions in business and product development. He has a background as head of business development in AstraZeneca, Actogenics and CV Therapeutics and most recently as CEO at TikoMed. As previously Vice President Business Development for CV Therapeutics, USA, he has many years of commercial and business development experience from the US market. Waas is currently Business Development Director at GUV, Gothenburg.
Bo Söderpalm, born 1959 is a board member in Sobrera Pharma since 2019. Söderpalm, M.D., Ph.D., is Professor and Chief physician at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg. He is the Co-Founder of Sobrera Pharma. Söderpalm is an experienced senior researcher and clinician since 30 years and has performed several clinical studies in the area of alcohol abuse.
Marcus Trummer, born 1980 is a board member in Sobrera Pharma since 2022. Trummer has extensive experience in board work, most recently with Byggmästare Anders J Ahlström Holding AB, an investment company working hands as an active investor. Trummer has over 15 years experience from working as board director, investing and strategy development.
Ulf Jonsson born 1949 is a board member in Sobrera Pharma since 2019. Jonsson, has 40 years of experience from the pharmaceutical industry, primarily within AstraZeneca. He has held senior, global positions covering areas such as pharmacokinetics, drug delivery, product development, portfolio management and business development. Ulf has extensive experience and knowledge of business development and negotiations in the pharma field and in the design and development of oral extended release formulations.
Anders Milton born 1947. Board member since 2020. Milton MD., PhD., has extensive experience in board work and a national and international network in healthcare, industry and among investors. Currently, Milton is Chairman of Vironova, Immune System Regulation,Stiftelsen Europaskolan i Strängnäs, Stiftelsen Motivationslyftet, and a member of several boards. Milton has previously served as Chairman of the Medical Assoc., SACO, Swedish Red Cross, People and Defense, and the World Medical Assoc. Milton has also been investigator of Swedish HIV & AIDS policy, Swedish psychiatry, donation and organ transplantation, and unwanted pregnancies, as well as a member of the Disaster Commission after the 2004 tsunami.
Andrea de Bejczy
Andrea de Bejczy, M.D., Ph.D., at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg is the Co-Founder of Sobrera Pharma. She is an experienced researcher and clinician and has performed several clinical studies in the area of alcohol abuse.
CEO of GU Ventures and chair of GOKAP. Expert at building new companies. Experienced board member in the life science sector including Alzinova AB, Cellink AB, Cereno Scientific AB, Metabogen AB, OnDosis AB, Ortoma AB, PExA AB and Toleranzia AB.